Maze Therapeutics (MAZE) Price to Sales (2025 - 2026)
Maze Therapeutics' Price to Sales came in at 82.81 for Q2 2026, down 61.5% from 215.22 a year earlier but up 11.6% from the prior quarter.
Powered by 
Analysis
Maze Therapeutics (MAZE) Price to Sales (2025 - 2026) Analysis & Trends
Going back to Q1 2025, Maze Therapeutics' Price to Sales data covers 4 quarters.
- The five-year range for quarterly Price to Sales is 1.88 (Q1 2025) to 215.22 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Maze Therapeutics | 1.47 Bn | 1.47 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.81 |
| Mar 31, 2026 | 74.23 |
| Jun 30, 2025 | 215.22 |
| Mar 31, 2025 | 1.88 |
API Access
Maze Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=MAZE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "MAZE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=MAZE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();